# Anteris Technologies Global Corp.: filings

AVR · Nasdaq · CIK 2011514 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/avr.md) · [Financials](/companies/avr/financials.md) · [Filings](/companies/avr/filings.md) · [Insiders](/companies/avr/insiders.md)

## Reports and events: 56 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 42, 4 37, 3 13, 424B3 12, SCHEDULE 13G/A 11, SCHEDULE 13G 6, 10-Q 5, CORRESP 5, UPLOAD 5, 4/A 4, DRS/A 4, EFFECT 4, 424B5 3, DEFA14A 3, DRSLTR 3, PRE 14A 3, 10-K 2, DEF 14A 2, FWP 2, S-1 2, SEC STAFF LETTER 2, 10-K/A 1, 424B4 1, 8-A12B 1, ARS 1, CERT 1, D 1, DRS 1, POS AM 1, POS EX 1, S-1/A 1, S-3 1, S-3ASR 1, S-8 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-23 | 07:30 ET | [8-K](/filings/0001140361-26-037392.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-037392 |
| 2026-09-17 | 17:00 ET | [8-K](/filings/0001140361-26-037002.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-037002 |
| 2026-09-08 | 07:01 ET | [8-K](/filings/0001140361-26-035840.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-035840 |
| 2026-08-12 | 19:07 ET | [8-K](/filings/0001140361-26-032296.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-032296 |
| 2026-08-11 | 16:05 ET | [10-Q](/filings/0001140361-26-032232.md) | Quarterly report, period 2026-06-30 | 0001140361-26-032232 |
| 2026-08-03 | 09:05 ET | [8-K](/filings/0001140361-26-030586.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-030586 |
| 2026-07-31 | 08:38 ET | [8-K](/filings/0001140361-26-030355.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-030355 |
| 2026-05-22 | 17:15 ET | [8-K](/filings/0001140361-26-022633.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001140361-26-022633 |
| 2026-05-13 | 20:55 ET | [8-K](/filings/0001140361-26-020901.md) | 5.02 Departure or appointment of officers or directors | 0001140361-26-020901 |
| 2026-05-13 | 20:39 ET | [8-K](/filings/0001140361-26-020896.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-020896 |
| 2026-05-12 | 16:06 ET | [10-Q](/filings/0001140361-26-020806.md) | Quarterly report, period 2026-03-31 | 0001140361-26-020806 |
| 2026-04-29 | 16:47 ET | [8-K](/filings/0001140361-26-017846.md) | 1.02 Termination of a material agreement | 0001140361-26-017846 |
| 2026-04-23 | 17:13 ET | [8-K](/filings/0001140361-26-016435.md) | 1.01 Entry into a material agreement | 0001140361-26-016435 |
| 2026-03-03 | 16:28 ET | [8-K](/filings/0001140361-26-007568.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-007568 |
| 2026-02-27 | 18:12 ET | [8-K](/filings/0001140361-26-007003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-007003 |
| 2026-02-26 | 16:07 ET | [10-K](/filings/0001140361-26-006977.md) | Annual report, period 2025-12-31 | 0001140361-26-006977 |
| 2026-01-29 | 17:06 ET | [SCHEDULE 13D](/filings/0001437749-26-002429.md) | Ownership report, active investor | 0001437749-26-002429 |
| 2026-01-22 | 17:18 ET | [8-K](/filings/0001140361-26-002070.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-002070 |
| 2026-01-22 | 06:18 ET | [8-K](/filings/0001140361-26-001938.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001140361-26-001938 |
| 2025-12-15 | 06:05 ET | [8-K](/filings/0001140361-25-045444.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-045444 |
| 2025-12-04 | 06:02 ET | [8-K](/filings/0001140361-25-044257.md) | 5.07 Shareholder vote results | 0001140361-25-044257 |
| 2025-12-01 | 16:42 ET | [8-K](/filings/0001140361-25-043801.md) | 1.02 Termination of a material agreement | 0001140361-25-043801 |
| 2025-11-26 | 16:35 ET | [S-1](/filings/0001140361-25-043521.md) | Registration statement | 0001140361-25-043521 |
| 2025-11-17 | 06:11 ET | [8-K](/filings/0001140361-25-042395.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-042395 |
| 2025-11-13 | 17:36 ET | [8-K](/filings/0001140361-25-041723.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-041723 |
| 2025-11-12 | 16:06 ET | [10-Q](/filings/0001140361-25-041643.md) | Quarterly report, period 2025-09-30 | 0001140361-25-041643 |
| 2025-11-10 | 16:52 ET | [DEF 14A](/filings/0001140361-25-041377.md) | Proxy statement, period 2025-12-03 | 0001140361-25-041377 |
| 2025-11-03 | 07:45 ET | [8-K](/filings/0001140361-25-040087.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-040087 |
| 2025-10-28 | 21:11 ET | [8-K](/filings/0001140361-25-039514.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-039514 |
| 2025-10-27 | 17:26 ET | [8-K](/filings/0001140361-25-039496.md) | 3.02 Unregistered sale of equity; 8.01 Other events | 0001140361-25-039496 |
| 2025-10-24 | 17:10 ET | [8-K](/filings/0001140361-25-039290.md) | 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-039290 |
| 2025-10-15 | 16:49 ET | [8-K](/filings/0001140361-25-038210.md) | 5.08 Item not in the standard list; 8.01 Other events | 0001140361-25-038210 |
| 2025-10-15 | 09:29 ET | [8-K](/filings/0001140361-25-038166.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-038166 |
| 2025-09-29 | 11:00 ET | [8-K](/filings/0001140361-25-036430.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001140361-25-036430 |
| 2025-09-19 | 06:02 ET | [8-K](/filings/0001140361-25-035449.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-035449 |
| 2025-09-11 | 09:07 ET | [8-K](/filings/0001140361-25-034636.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-034636 |
| 2025-09-04 | 06:01 ET | [8-K](/filings/0001140361-25-033879.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-033879 |
| 2025-08-18 | 06:01 ET | [DEF 14A](/filings/0001140361-25-031606.md) | Proxy statement, period 2025-09-04 | 0001140361-25-031606 |
| 2025-08-12 | 20:56 ET | [8-K](/filings/0001140361-25-030297.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-030297 |
| 2025-08-11 | 15:01 ET | [10-Q](/filings/0001140361-25-030146.md) | Quarterly report, period 2025-06-30 | 0001140361-25-030146 |
| 2025-08-07 | 07:00 ET | [8-K](/filings/0001140361-25-029341.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-029341 |
| 2025-07-29 | 17:19 ET | [8-K](/filings/0001140361-25-027864.md) | 1.01 Entry into a material agreement | 0001140361-25-027864 |
| 2025-06-09 | 07:00 ET | [8-K](/filings/0001140361-25-021859.md) | 5.02 Departure or appointment of officers or directors | 0001140361-25-021859 |
| 2025-05-14 | 19:00 ET | [8-K](/filings/0001140361-25-018725.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-018725 |
| 2025-05-13 | 17:22 ET | [10-Q](/filings/0001140361-25-018701.md) | Quarterly report, period 2025-03-31 | 0001140361-25-018701 |
| 2025-04-29 | 16:34 ET | [10-K/A](/filings/0001140361-25-016352.md) | Annual report, amended, period 2024-12-31 | 0001140361-25-016352 |
| 2025-03-31 | 06:01 ET | [8-K](/filings/0001140361-25-011072.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-011072 |
| 2025-03-21 | 19:32 ET | [8-K](/filings/0001140361-25-009748.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-009748 |
| 2025-03-13 | 18:03 ET | [8-K](/filings/0001140361-25-008474.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-008474 |
| 2025-03-12 | 17:02 ET | [10-K](/filings/0001140361-25-008455.md) | Annual report, period 2024-12-31 | 0001140361-25-008455 |

Page 1 of 2. [Older](/companies/avr/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 09:01 ET. No prices; not investment advice.